JR
James R. Kasinger sold $119K of CRSP stock
James R. Kasinger, General Counsel and Secretary of CRISPR Therapeutics AG (CRSP), sold 1,990 shares of CRSP stock worth $119K, per an SEC Form 4 filed Oct 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 6, 2026, 2 days before it was made public.
CRSP has moved -25.6% since the trade date, from $54.00 to $40.19 (Nov 18, 2026 close).
- Traded
- Oct 6, 2026
- Disclosed
- Oct 8, 2026
- Filing delay
- 2 days
- Price since
- -25.6%
- Role
- General Counsel and Secretary
- Source
- SEC Form 4